New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration-Reference-Cited by-同舟云学术

New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration

Published:2016-07-19 Issue:1 Volume:359 Page:171-181
ISSN:1521-0103
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:Journal of Pharmacology and Experimental Therapeutics

Author:

Lacko E.,Riba P.,Giricz Z.,Varadi A.,Cornic L.,Balogh M.,Kiraly K.,Csek K.,Mousa S. A.,Hosztafi S.,Schafer M.,Zadori Z. S.,Helyes Z.,Ferdinandy P.,Furst S.,Al-Khrasani M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference43 articles.

1. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain

2. DAMGO and 6β-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens

3. Perineurial defect and peripheral opioid analgesia in inflammation

4. Opioid peptides and receptors in joint tissues: Study in the rat

5. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thermoresponsive Polymeric Hydromorphone Prodrug Provides Sustained Local Analgesia without Apparent Adverse Effects;Molecular Pharmaceutics;2024-02-27

2. Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis;Molecules;2023-11-24

3. New Insights into the Opioid Analgesic Profile of cis-(−)-N-Normetazocine-derived Ligands;Molecules;2023-06-17

4. Peripheralization Strategies Applied to Morphinans and Implications for Improved Treatment of Pain;Molecules;2023-06-14

5. Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine;Antioxidants & Redox Signaling;2022-01-01